COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,973 Articles (22,604 medRxiv, 8,369 bioRxiv)

Most recent first Previous |  Page 1663: Articles 16621-16630  | Next

Determinants of COVID-19 outcomes: A systematic review.
Crankson, S., Pokhrel, S., Anokye, N. K.
10.1101/2021.03.21.21254068 — Posted: 2021-03-23 Discussion: Onsite
Factors influencing COVID-19 vaccination uptake in an elderly sample in Poland
Malesza, M., Bozym, M.
10.1101/2021.03.21.21254047 — Posted: 2021-03-23
Addressing disruptions in childhood routine immunisation services during the COVID-19 pandemic: perspectives and lessons learned from Liberia, Nepal, and Senegal
Dixit, S. M., Sarr, M., Gueye, D. M., Muther, K., Yarnko, T. R., Bednarczyk, R. A., Clarke, A. T., Diallo, A., Dounebaine, B., Ellis, A., Fullman, N., Gerthe, N., Guatam, J. S., Hester, K., Ikilezi, G., Mboup, S., Rajbhandari, R. M., Phillips, D. E., Freeman, M. C.
10.1101/2021.03.18.21252686 — Posted: 2021-03-23
Recurrence quantification analysis of heart rate variability is a COVID-safe alternative to gas analysis in the detection of metabolic thresholds
Zimatore, G., Falcioni, L., Gallotta, M., Bonavolnta, V., Campanella, M., De Spirito, M., Guidetti, L., Baldari, C.
10.1101/2021.03.22.436405 — Posted: 2021-03-22
COVID-19 Survivors' Reports of the Timing, Duration, and Health Impacts of Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
Lambert, N., Survivor Corps, , El-Azab, S. A., Ramrakhiani, N. S., Barisano, A., Yu, L., Taylor, K., Esperanca, A., Downs, C. A., Abrahim, H. L., Pinto, M. D., Chakraborty, R., Borelli, J. L.
10.1101/2021.03.22.21254026 — Posted: 2021-03-22 Discussion: Onsite
Replicative fitness SARS-CoV-2 20I/501Y.V1 variant in a human reconstituted bronchial epithelium
Touret, F., Luciani, L., Baronti, C., Cochin, M., Driouich, J.-S., Gilles, M., Thirion, L., Nougairede, A., de Lamballerie, X.
10.1101/2021.03.22.436427 — Posted: 2021-03-22
Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2
Dicken, S. J., Murray, M. J., Thorne, L. G., Reuschl, A.-K., Forrest, C., Ganeshalingham, M., Muir, L., Kalemera, M. D., Palor, M., McCoy, L. E., Jolly, C., Towers, G. J., Reeves, M., Grove, J.
10.1101/2021.03.22.436468 — Posted: 2021-03-22
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals
Camara, C., Lozano-Ojalvo, D., Lopez-Granados, E., Paz-Artal, E., Pion, M., Correa-Rocha, R., Ortiz, A., Lopez-Hoyos, M., Erro Iribarren, M., Portoles, J., Portoles, P., Perez-Olmeda, M., Oteo-Iglesias, J., Berin, C., Guccione, E., Bertoletti, A., Ochando, J.
10.1101/2021.03.22.436441 — Posted: 2021-03-22
TMPRSS2 inhibitor discovery facilitated through an in silico and biochemical screening platform
Peiffer, A. L., Garlick, J. M., Wu, Y., Soellner, M. B., Brooks, C. L., Mapp, A. K.
10.1101/2021.03.22.436465 — Posted: 2021-03-22
Structural modeling of the SARS-CoV-2 Spike/human ACE2 complex interface can identify high-affinity variants associated with increased transmissibility
Gan, H. H., Twaddle, A., Marchand, B., Gunsalus, K.
10.1101/2021.03.22.436454 — Posted: 2021-03-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).